Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | BMY | AMGN | GILD | REGN | VRTX |
Company | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic |
Price Information | |||||
Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 53.00 | 284.22 | 72.92 | 971.04 | 420.30 |
High | 53.69 | 286.82 | 73.06 | 976.75 | 420.42 |
Low | 52.85 | 282.55 | 72.55 | 962.41 | 412.65 |
Last | 53.25 | 286.30 | 73.01 | 966.30 | 417.32 |
Change | +0.70 | +4.53 | +0.60 | +2.75 | -1.14 |
% Change | +1.33% | +1.61% | +0.83% | +0.29% | -0.27% |
Volume | 13,077,600 | 2,256,300 | 7,747,500 | 314,700 | 905,400 |
20-Day Average Volume | 20,769,045 | 3,134,110 | 7,477,905 | 442,695 | 1,045,085 |
Previous Close | 52.55 | 281.77 | 72.41 | 963.55 | 418.46 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 52.40 | 275.97 | 73.48 | 967.01 | 415.37 |
20-Day Raw Stochastic | 62.50% | 97.21% | 25.41% | 44.10% | 38.30% |
20-Day Relative Strength | 59.38% | 53.75% | 43.89% | 54.40% | 50.28% |
Weighted Alpha | -19.90 | +18.50 | -12.50 | +23.30 | +30.80 |
Today's Opinion | 8% Buy | 40% Buy | 88% Sell | 80% Buy | 56% Buy |
Previous Opinion | 8% Sell | 24% Buy | 88% Sell | 80% Buy | 56% Buy |
Last Month's Opinion | 56% Sell | 40% Buy | 40% Sell | 100% Buy | 100% Buy |
Performance | |||||
5-Days | |||||
%Chg | +2.64% since 03/20/24 | +4.85% since 03/20/24 | -1.31% since 03/20/24 | -0.07% since 03/20/24 | +1.26% since 03/20/24 |
Low | 51.52 on 03/22/24 | 274.39 on 03/21/24 | 72.11 on 03/26/24 | 952.47 on 03/25/24 | 412.19 on 03/22/24 |
High | 53.69 on 03/27/24 | 286.82 on 03/27/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 | 420.42 on 03/27/24 |
1-Month | |||||
%Chg | +5.42% since 02/27/24 | +2.80% since 02/27/24 | -0.01% since 02/27/24 | -2.72% since 02/27/24 | -3.16% since 02/27/24 |
Low | 50.28 on 02/29/24 | 268.17 on 03/15/24 | 71.92 on 02/29/24 | 947.37 on 03/20/24 | 406.97 on 03/15/24 |
High | 55.03 on 03/13/24 | 286.82 on 03/27/24 | 76.21 on 03/11/24 | 998.33 on 02/28/24 | 433.99 on 03/04/24 |
3-Month | |||||
%Chg | +3.98% since 12/27/23 | -0.08% since 12/27/23 | -9.16% since 12/27/23 | +10.51% since 12/27/23 | +2.27% since 12/27/23 |
Low | 47.58 on 02/06/24 | 268.17 on 03/15/24 | 71.37 on 02/16/24 | 871.39 on 01/02/24 | 403.43 on 01/02/24 |
High | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 | 448.40 on 01/30/24 |
6-Month | |||||
%Chg | -8.02% since 09/27/23 | +6.44% since 09/27/23 | -3.36% since 09/27/23 | +16.06% since 09/27/23 | +19.35% since 09/27/23 |
Low | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 71.37 on 02/16/24 | 769.19 on 10/27/23 | 341.85 on 10/03/23 |
High | 58.46 on 09/29/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 | 448.40 on 01/30/24 |
Key Statistics | |||||
Market Capitalization, $K | 107,924,920 | 153,433,600 | 90,903,080 | 106,063,024 | 107,797,104 |
Shares Outstanding, K | 2,026,759 | 535,919 | 1,245,077 | 109,762 | 258,308 |
Annual Sales | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 | 9,869,200,000 |
Annual Net Income | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 | 3,619,600,000 |
Last Quarter Sales | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 | 2,517,700,000 |
Last Quarter Net Income | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 | 968,800,000 |
60-Month Beta | 0.38 | 0.58 | 0.18 | 0.11 | 0.35 |
Per-Share Information | |||||
Most Recent Earnings | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 | 4.20 on 02/05/24 |
Latest Earnings Date | 04/25/24 | 04/25/24 | 04/25/24 | 05/02/24 | 05/06/24 |
Most Recent Dividend | 0.600 on 01/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
Next Ex-Dividends Date | 04/04/24 | 05/16/24 | 03/14/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 7.01 | 15.11 | 10.78 | 25.64 | 31.14 |